Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
暂无分享,去创建一个
J. Rosenfeld | I. Scheffer | H. Mefford | D. Goldstein | S. Petrovski | F. Xia | E. Heinzen | G. Enns | J. Bernstein | S. Küry | K. Wierenga | B. Cogné | T. Dudding-Byth | S. Mercier | M. Bialer | B. Isidor | A. Basinger | S. Bézieau | P. Corre | M. Mehaffey | Sophie Colombo | T. Grebe | T. Besnard | Zhong Ren | C. Myers | K. Anyane-Yeboa | P. Hemati | J. Riviello | Emily Becraft | Alexandrea F. Wadley | Anya Revah Politi | Xiaoling Zhu | I. Andrews | A. Schneider | G. Wallace | A. B. Rosen | S. Schelley | J. Dalton | X. Latypova | S. Schmitt | E. Guzmán | C. Moore | L. Bier | P. Karachunski | N. Shur | Joanne Nguyen | Amy L. Schneider | Z. Ren | Louise E Bier | Natasha E. Shur | Alice A. Basinger | Candace T. Myers
[1] D. Licatalosi,et al. FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.
[2] Kenny Q. Ye,et al. De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.
[3] Damian Smedley,et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data , 2014, Nucleic Acids Res..
[4] R. Gibbs,et al. Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities , 2011, Genome Biology.
[5] Stephan J Sanders,et al. A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.
[6] M. Bucan,et al. From Mouse to Human: Evolutionary Genomics Analysis of Human Orthologs of Essential Genes , 2013, PLoS genetics.
[7] S Purcell,et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.
[8] Epilepsy Phenome,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[9] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[10] K. Rauen,et al. The RASopathies. , 2013, Annual review of genomics and human genetics.
[11] Jean-Michel Claverie,et al. The human gene damage index as a gene-level approach to prioritizing exome variants , 2015, Proceedings of the National Academy of Sciences.
[12] L. Jan,et al. Molecular basis for interactions of G protein betagamma subunits with effectors. , 1998, Science.
[13] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[14] De novo mutations in epileptic encephalopathies , 2013 .
[15] R. Doolittle,et al. Repetitive segmental structure of the transducin beta subunit: homology with the CDC4 gene and identification of related mRNAs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Shendure,et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes , 2012, Nature Genetics.
[17] Yujun Han,et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios , 2015, Genetics in Medicine.
[18] Stephan J Sanders,et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.
[19] Michael R. Johnson,et al. De novo mutations in the classic epileptic encephalopathies , 2013, Nature.
[20] J. Rosenfeld,et al. Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions , 2010, American journal of medical genetics. Part A.
[21] S. Sprang,et al. The structure of the G protein heterotrimer Giα1 β 1 γ 2 , 1995, Cell.
[22] M. Daly,et al. Interpreting de novo Variation in Human Disease Using denovolyzeR , 2015, Current protocols in human genetics.
[23] E. Banks,et al. De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.
[24] B. Ebert,et al. Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance , 2014, Nature Medicine.
[25] Kelly Schoch,et al. Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.
[26] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[27] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[28] L. Jan,et al. Molecular Basis for Interactions of G Protein βγ Subunits with Effectors , 1998 .
[29] Judith A. Blake,et al. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..
[30] H. Hamm,et al. The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.
[31] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[32] D. Goldstein,et al. Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.
[33] S. Sprang,et al. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. , 1995, Cell.
[34] K. Rauen,et al. Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome , 2011, Clinical genetics.
[35] Tomas W. Fitzgerald,et al. Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.